Zollinger-Ellison Syndrome

Zollinger-Ellison Syndrome is a rare condition that causes severe stomach ulcers. It happens because the body makes too much stomach acid. This excess acid is usually caused by a tumor (called a gastrinoma) that produces too much of a hormone called gastrin. This tumor is often found in the pancreas or near the spine.

Condition

What people with Zollinger-Ellison Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried Prilosec (Omeprazole) for Zollinger-Ellison Syndrome?

NameHow it went

About Zollinger-Ellison Syndrome

What It Is

Zollinger-Ellison syndrome (ZES) is a rare condition in which one or more tumors called gastrinomas release large amounts of gastrin, the hormone that tells the stomach to make acid. Most gastrinomas grow in the duodenum (the first part of the small intestine) or the pancreas. The result is a stomach that produces far more acid than it should, around the clock. That excess acid causes the condition's main problems: peptic ulcers that are often severe, keep coming back or don't heal with usual treatment, and acid reflux (gastroesophageal reflux disease, or GERD). Common symptoms are burning or gnawing pain in the upper belly, heartburn, nausea, weight loss and diarrhea, which can be the only symptom. Gastrinomas are a type of neuroendocrine tumor, and more than half are cancerous, so ZES involves two problems at once: controlling the acid and managing the tumor itself.

Causes & Risk Factors

The direct cause is the gastrinoma. In most people, doctors don't know why the tumor formed, and this sporadic form isn't linked to anything a person did or ate. Stress, food and lifestyle do not cause ZES, although they can influence how ulcer symptoms feel. About 20% to 25% of people with ZES have multiple endocrine neoplasia type 1 (MEN1), an inherited condition that causes tumors in several hormone-producing glands, most often the parathyroid glands, the pancreas and duodenum, and the pituitary. MEN1 runs in families, so a personal or family history of it raises the likelihood of ZES. People with MEN1 often develop ZES earlier in life and usually have several small tumors rather than one. ZES is most often diagnosed between ages 20 and 50 and is slightly more common in men.

How It's Diagnosed

Because ZES is rare and its symptoms overlap with common ulcers and reflux, the diagnosis is often made late. Doctors become suspicious when ulcers are severe, keep coming back or lead to complications, when ulcers occur without the usual causes (the stomach bacterium H. pylori or regular use of anti-inflammatory pain relievers such as ibuprofen), when chronic diarrhea accompanies ulcers or reflux, or when someone has MEN1 or a family history of it. The first test is usually a fasting blood gastrin level. Almost everyone with ZES has a high level, but a high level alone does not prove the diagnosis, because other things raise gastrin too, including proton pump inhibitors (PPIs), the most common acid-reducing medicines. The key is showing that gastrin is high while the stomach is still very acidic. A gastrin level more than 10 times the upper limit of normal, measured while stomach fluid is strongly acidic (a pH of 2 or lower), establishes the diagnosis in most cases. When results are less clear, a secretin stimulation test can help: secretin is a hormone given by IV that makes gastrinomas release more gastrin, while it has little effect on gastrin from other causes. Since acid-reducing medicine affects these tests, a doctor may adjust it beforehand. This should only be done under a specialist's guidance, because stopping it suddenly can be dangerous for someone who does have ZES. An upper endoscopy (a camera passed through the mouth) looks at the esophagus, stomach and duodenum for ulcers and damage. To find the tumor and see whether it has spread, doctors use CT or MRI scans, endoscopic ultrasound and a specialized PET scan that highlights neuroendocrine tumors. Gastrinomas can be very small and hard to find. People diagnosed with ZES are usually also checked for MEN1, starting with blood calcium and parathyroid hormone levels.

Treatment Options

Treatment has two goals: control the acid and deal with the tumor. Acid control comes first, and PPIs are the mainstay. These medicines, such as omeprazole and pantoprazole (Protonix), block the pumps in the stomach lining that release acid. They relieve pain and diarrhea, heal ulcers and prevent complications such as bleeding. People with ZES often need higher doses than are used for ordinary reflux, especially at first, and the dose is then adjusted to the lowest amount that keeps acid under control. Because most gastrinomas cannot be completely removed, many people take a PPI for life. Missing doses or stopping suddenly can bring back severe ulcers and reflux, so any change should be planned with the care team. Surgery is the only treatment that can cure ZES. For people without MEN1 whose tumor can be found and has not spread widely, surgeons generally recommend removing it. This cures some people and lowers the chance of the cancer spreading, although the tumor can come back years later, and some people still need acid medicine afterward. In MEN1, surgery is usually reserved for larger tumors, because people typically have many small tumors that are hard to remove completely, and treating overactive parathyroid glands can also help lower acid. When a gastrinoma has spread, often to the liver, treatment is guided by a team experienced in neuroendocrine tumors. Options can include surgery or other procedures to remove or destroy liver tumors, medicines that slow tumor growth, targeted drugs, chemotherapy and radioactive treatments that home in on neuroendocrine tumor cells. These aim to control the cancer for as long as possible; acid control with PPIs continues alongside them.

What to Expect

With modern acid-reducing medicine, ulcer complications that were once the main danger of ZES are now usually preventable. For most people, symptoms settle once the right PPI dose is found, and daily life largely returns to normal. Long-term outlook depends mostly on the tumor: whether it was removed completely and whether it had spread to the liver. Many people live for many years after diagnosis, particularly when the tumor can be removed completely, but outcomes vary widely and are best discussed with a specialist who knows the details of the case. ZES is usually a long-term condition that needs ongoing care, often at a center with experience in neuroendocrine tumors. Follow-up typically includes repeat gastrin levels, periodic imaging to watch for tumor growth or return, and sometimes endoscopy. Long-term PPI use can lower vitamin B12, so levels are usually checked from time to time. People with MEN1 have additional regular checks for the other glands it affects, and genetic counseling is recommended for people with ZES and their families.

When to Seek Help

See a doctor if you have ulcers that keep coming back or don't heal, ulcers without an obvious cause, or long-lasting diarrhea together with heartburn or upper belly pain, especially if you have MEN1 or a family history of it. If you are already treated for ZES, contact your care team when symptoms return or worsen, diarrhea or weight loss persists, or you need to stop or change your acid medicine for any reason. Contact your care team right away for black or tarry stools, blood in your stool, persistent vomiting, or pain or difficulty swallowing. Get emergency care for vomit that contains blood or looks like coffee grounds, or for sudden, severe belly pain that doesn't go away. Call 911 if bleeding comes with fainting, severe dizziness or a racing pulse.

Questions to Ask Your Doctor

  1. 1.What do my gastrin levels and other test results show, and do I need any further testing to confirm the diagnosis?
  2. 2.Should I be tested for MEN1, and should my relatives be tested too?
  3. 3.Has the tumor been found, has it spread, and is surgery a realistic option for me?
  4. 4.What PPI dose do I need, how will we know it is controlling the acid, and what should I do if I miss doses or can't take it?
  5. 5.How often will I need imaging, blood tests or endoscopy, and should my care be coordinated with a neuroendocrine tumor center?

Last reviewed • Oct 2026

Educational content, not medical advice.